These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Savene® (dexrazoxane) use in clinical practice. Fontaine C; Noens L; Pierre P; De Grève J Support Care Cancer; 2012 May; 20(5):1109-12. PubMed ID: 22278308 [TBL] [Abstract][Full Text] [Related]
5. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience. Frost A; Gmehling D; Azemar M; Unger C; Mross K Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015 [TBL] [Abstract][Full Text] [Related]
6. Totect: a new agent for treating anthracycline extravasation. Schulmeister L Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623 [TBL] [Abstract][Full Text] [Related]
8. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation. Tyson AM; Gay WE Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757 [TBL] [Abstract][Full Text] [Related]
9. The use of dexrazoxane for the prevention of anthracycline extravasation injury. Hasinoff BB Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055 [TBL] [Abstract][Full Text] [Related]
10. Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation. Arroyo PA; Perez RU; Feijoo MA; Hernandez MA J Cancer Res Ther; 2010; 6(4):573-4. PubMed ID: 21358106 [TBL] [Abstract][Full Text] [Related]
12. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Mouridsen HT; Langer SW; Buter J; Eidtmann H; Rosti G; de Wit M; Knoblauch P; Rasmussen A; Dahlstrøm K; Jensen PB; Giaccone G Ann Oncol; 2007 Mar; 18(3):546-50. PubMed ID: 17185744 [TBL] [Abstract][Full Text] [Related]
13. Dexrazoxane in anthracycline extravasation. Langer SW; Sehested M; Jensen PB; Buter J; Giaccone G J Clin Oncol; 2000 Aug; 18(16):3064. PubMed ID: 10944144 [No Abstract] [Full Text] [Related]
14. Other uses of dexrazoxane: Savene, the first proven antidote against anthracycline extravasation injuries. Langer SW; Jensen PB; Sehested M Cardiovasc Toxicol; 2007; 7(2):151-3. PubMed ID: 17652821 [TBL] [Abstract][Full Text] [Related]
15. Dexrazoxane-a promising antidote in the treatment of accidental extravasation of anthracyclines. Jensen JN; Lock-Andersen J; Langer SW; Mejer J Scand J Plast Reconstr Surg Hand Surg; 2003; 37(3):174-5. PubMed ID: 12841619 [TBL] [Abstract][Full Text] [Related]
16. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Kane RC; McGuinn WD; Dagher R; Justice R; Pazdur R Oncologist; 2008 Apr; 13(4):445-50. PubMed ID: 18448560 [TBL] [Abstract][Full Text] [Related]
17. Re: Totect: a new agent for treating anthracycline extravasation. Ward MS Clin J Oncol Nurs; 2007 Oct; 11(5):613; author reply 613. PubMed ID: 17962168 [No Abstract] [Full Text] [Related]